Antioxidants and methimazole in the treatment of Graves' disease: Effect on urinary malondialdehyde levels

Clinica Chimica Acta

Volumn 352, Issue 1-2, 2005, Pages 115-120

  Guerra, Liliana N ^a,b   Ríos De Molina, María Del Carmen ^b   Miler, Eliana A ^b   Moiguer, Silvia ^a   Karner, Mirta ^a   Burdman, José A ^a,c  

^a Hospital Israelita   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

Author keywords

Hyperthyroidism; Malondialdehyde; Methimazole (MMI)

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE; THIAMAZOLE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GRAVES DISEASE; HEART RATE; HUMAN; HYPERTHYROIDISM; MALE; OXIDATIVE STRESS; PARAMETER; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HEART RATE; HUMANS; MALE; MALONDIALDEHYDE; METHIMAZOLE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 11844271928     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.08.020     Document Type: Article

References (25)

1. T. Mano, R. Shinohara, Y. Sawai, N. Oda, T. Nishida, and T. Mokuno Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle J. Endocrinol. 145 1995 131 136
2. L.A. Videla, T. Sir, and C. Wolff Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment Free Radic. Res. Commun. 5 1988 1 10
3. V. Fernandez, K. Simizu, S.B. Barros, L.A. Azzalis, R. Pimentel, and V.B. Junqueira Effects of hyperthyroidism on rat live glutathione metabolism: related enzymes' activities, efflux and turnover Endocrinology 129 1991 85 91
4. E.A. Lissi, M. Salim-Hanna, T. Sir, and L.A. Videla Is spontaneous urinary visible chemiluminescence a reflection of in vivo oxidative stress? Free Radic. Biol. Med. 12 1992 317 322
5. P. Venditti, M. Balestrini, S. Di Meo, and T. De Leo Effect of thyroid state on lipid peroxidation, antioxidant defenses, and susceptibility to oxidative stress in rat tissues J. Endocrinol. 155 1997 151 157
6. M. Abalovich, S. Llesuy, S. Gutierrez, and M. Repetto Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments Clin. Endocrinol. 59 2003 321 327
7. G. Tapia, I. Pepper, G. Smok, and L.A. Videla Kumpfer cell function in thyroid hormone-induced liver oxidative stress in the rat Free Radic. Res. 26 1997 267 279
8. L.N. Guerra, S. Moiguer, M. Karner, M.C. Rios de Molina, C.M. Sreider, and J.A. Burdman Antioxidants in the treatment of Graves' disease IUBMB Life 51 2001 105 109
9. 2 scavenging Mol. Pharmacol. 60 2001 972 980
10. L. Hagfors, P. Leanderson, L. Skoldstam, J. Andersson, and G. Johansson Antioxidant intake, plasma antioxidants and oxidative stress in randomized, controlled, parallel, Mediterranean dietary innervation study on patients with rheumatoid arthritis Nutr. J. 2 2003 5 9
11. A. Aboutwerat, P.W. Pemberton, A. Smith, P.C. Burrows, R.F. McMahon, and S.K. Jain Oxidant stress in a significant feature of primary biliary cirrhosis Biochim. Biophys. Acta 1637 2003 142 150
12. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 310
13. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
14. S.A. Glantz Primer of biostatistics: the program 1992 McGraw Hill New York
15. Analytical Software, Statistix 8, Thallahase Florida, 2003.
16. V.K. Komosinska, K. Olczyk, E.J. Kucharz, C. Marcisz, K. Winsz-Szcotka, and A. Kotulska Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy Clin. Chim. Acta 300 2000 107 117
17. J. Bustamante, L.N. Guerra, J. Bredeston, J. Mordoh, and A. Boveris Melanin content and hydroperoxide metabolism in human melanoma cells Exp. Cell Res. 196 1991 172 176
18. C. Feillet-Coudray, F. Chone, F. Michel, E. Rock, P. Thieblot, and Rayssiguier Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes Clin. Chim. Acta 324 2002 25 30
19. J. Chehade, J. Kim, J.L. Pinas, and A.D. Mooradian Age-related changes in the thyroid hormone effects on malondialdehyde modified proteins in the rat heart Proc. Soc. Exp. Biol. Med. 222 1999 59 64
20. T. Mano, R. Shinohara, K. Iwase, M. Kotake, M. Kamada, and K. Uchimuro Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders Horm. Metab. Res. 29 1997 351 354
21. D.S. Cooper Antithyroid drugs N. Engl. J. Med. 321 1984 1353 1362
22. J. Sewerynek, J. Wiktorska, D. Nowak, and A. Lewinski Methimazole protection against oxidative stress induced by hyperthyroidism in Graves' disease Endocr. Regul. 34 2000 83 89
23. L.N. Guerra, M.C. Rios de Molina, M.F. Basso, S. Moiguer, M. Karner, and J.A. Burdman Thyroid hormone and oxidative metabolism: in vitro model Program 84th annual meeting of the endocrine society, San Francisco, CA 2002 290
24. Y. Aliciguzel, S.N. Ozdem, S.S. Ozdem, U. Karayalcin, S.L. Siedlak, and G. Perry Erythrocyte, plasma and serum antioxidant activities in untreated toxic multinodular goiter patients Free Radic. Biol. Med. 30 2001 665 670
25. L. Dumitriu, R. Bartoc, H. Ursu, M. Purice, and V. Ionescu Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism Endocrinology 26 1998 35 38